Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 01 Jul 2024 20:23:06 +0200Tue, 13 Feb 2024 11:49:00 +0100Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/vuewayHuman medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/vuewayTue, 13 Feb 2024 11:49:00 +0100Human medicineVueway : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6172-en.pdfVueway : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6172-en.pdfTue, 13 Feb 2024 11:37:06 +0100Human medicine